Overview
  • Transaction Name: Ligand Pharmaceuticals Incorporated / APEIRON Biologics AG
  • Acquirer: Ligand Pharmaceuticals Incorporated
  • Target: APEIRON Biologics AG
  • Seller: Sellers of APEIRON Biologics AG
  • Announcement Date: July 8, 2024
  • Status: Pending
Loading...
  • of